Sumant Kulkarni Free People Check 

( I'm Sumant Kulkarni)

Loading...

Images of Sumant Kulkarni

(1 - 1 from 1 )

News

(1 - 4 from 5
)

Biogen stock surges 16% as analysts mostly cheer positive results in...

www.marketwatch.com
Analysts were nearly all impressed by Biogen and Eisai’s positive results from a mid-stage trial of an Alzheimer’s treatment. But Leerink was a dissenter.

Biogen Stock Upgraded On Hope For Alzheimer's Disease Treatment

www.investors.com
Canaccord analyst Sumant Kulkarni updated Biogen to a buy rating from hold, though he trimmed his price target to 335 from The new ...

ORYZON to present at upcoming international conferenceswww.oryzon.com › news-events › news › oryzon-present-upcoming-intern...

www.oryzon.com
Sep 8, · ... Management of Johnson & Johnson, and Dr. Sumant Kulkarni, Managing Director Biotechnology Equity Research, Canaccord Genuity LLC.

What Will Biogen Do If Its Alzheimer's Drug Goes South? - Investor's ...www.investors.com › biogen-stock-can-sage-deal-save-it-aducanumab-flops

www.investors.com
Dec 4, · Canaccord Genuity analyst Sumant Kulkarni says the landscape for Biogen stock in "becomes more interesting with (the) Sage deal.
Related search requests for Sumant Kulkarni
Person "Kulkarni" (14)
Forename "Sumant" (187)
Name "Kulkarni" (4123)
Save as document
+1